Desbois et al. reported that TGF-β-activated fibroblasts contribute to an immune-suppressed environment by cytokine production in ovarian cancer (Desbois et al., 2020; Desbois and Wang, 2021). This evidence concerns the gene TGFB1 and ovarian carcinoma.